Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
Orthogonal Biologics, Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $256,565 in 2021. These are non-dilutive federal research grants, not equity financing. The company is based in Champaign, Illinois.
No investors recorded yet for Orthogonal Biologics, Inc..
Add an investorOrthogonal Biologics, Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Orthogonal Biologics, Inc..
Add diversity data